About

Pat has a Ph.D. in Microbiology and Immunology from The University of Health Sciences / The Chicago Medical School (now the Rosalind Franklin Institute (North…

Pat has a Ph.D. in Microbiology and Immunology from The University of Health Sciences / The Chicago Medical School (now the Rosalind Franklin Institute (North Chicago, IL) (1994)). He also completed post-doctoral studies at The National Cancer Institute (1994-1996) where he developed novel approaches for gene therapy of melanoma. Pat has been an attorney (IL) since 1999 after graduating from Chicago-Kent College of Law, which was recently ranked as one of the top five law schools for Intellectual Property in the U.S. (U.S. News and World Report link). Pat also has a B.A. in Biology from Augustana College (Rock Island, IL; 1989) where he was on two NCAA Division III National Championship football teams (1985, 1986). He currently resides in Center Valley, PA.

More Posts

Regents of the University of Minnesota v. Gilead Sciences, Inc.

Docket No. 2021-2168 (IPR 2017-01712) (https://cafc.uscourts.gov/opinions-orders/21-2168.OPINION.3-6-2023_2090143.pdf)

LOURIE, DYK, STOLL

March 6, 2023

Brief Summary:   Board IPR FWD finding UM’s genus claims lack a sufficient written description in priority applications and are therefore anticipated affirmed.

Summary:  UM appealed USPTO Board IPR final written decision (FWD) holding claims 1-9, 11-21 and 23-28 of US 8,815,830 “directed to phosphoramidate prodrugs of nucleoside derivatives that prevent viruses from reproducing or cancerous tumors from growing” (claim 1, including multiple Markush groups, patent including separately claimed subgenera).  Gilead’s FDA approved sofosbuvir used to

Continue Reading Board finding of no written description of genus claims in priority applications and anticipation affirmed

About

Pat has a Ph.D. in Microbiology and Immunology from The University of Health Sciences / The Chicago Medical School (now the Rosalind Franklin Institute (North…

Pat has a Ph.D. in Microbiology and Immunology from The University of Health Sciences / The Chicago Medical School (now the Rosalind Franklin Institute (North Chicago, IL) (1994)). He also completed post-doctoral studies at The National Cancer Institute (1994-1996) where he developed novel approaches for gene therapy of melanoma. Pat has been an attorney (IL) since 1999 after graduating from Chicago-Kent College of Law, which was recently ranked as one of the top five law schools for Intellectual Property in the U.S. (U.S. News and World Report link). Pat also has a B.A. in Biology from Augustana College (Rock Island, IL; 1989) where he was on two NCAA Division III National Championship football teams (1985, 1986). He currently resides in Center Valley, PA.

Subscribe: Subscribe via RSS